Recruiting KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line) NCT07406633 Conditions Digestive System Diseases, Digestive System Neoplasms, GIST, +12 more Locations USC Norris Comprehensive Cancer Center — Los Angeles, California, United States Mayo Clinic - Jacksonville — Jacksonville, Florida, United States Sylvester Comprehensive Cancer Center — Miami, Florida, United States Moffitt Cancer Center — Tampa, Florida, United States View all 16 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies NCT04566614 Conditions Biliary Tract Diseases, Biliary Tract Neoplasms, Colonic Diseases, +33 more Locations Royal Marsden Hospital — Sutton, Surrey, United Kingdom View Trial Details
Completed Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure NCT04193553 Conditions Gastro Intestinal Stromal Tumour, Neoplasm Metastasis, Neoplasms, +3 more Locations Centre Antoine LACASSAGNE — Nice, Alpes-Maritimes, France Hopital de La Timone — Marseille, Bouches Du Rhône, France Institut Paoli Calmette — Marseille, Bouches-du-Rhône, France Centre Georges-François Leclerc — Dijon, Bourgogne-Franche-Comté, France View all 14 locations View more locations Show fewer locations Loading locations... View Trial Details